3/25
08:09 pm
bhvn
Mixed signals cloud the orphan drug market [Yahoo! Finance]
Medium
Report
Mixed signals cloud the orphan drug market [Yahoo! Finance]
3/23
01:42 pm
bhvn
Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential [Yahoo! Finance]
Low
Report
Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential [Yahoo! Finance]
3/21
08:16 pm
bhvn
This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash [Yahoo! Finance]
Medium
Report
This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash [Yahoo! Finance]
3/19
07:30 am
bhvn
Biohaven's Phase 2 Obesity Study with Taldefgrobep Alfa, a Novel Myostatin-Activin Pathway Inhibitor, Completes Enrollment
Low
Report
Biohaven's Phase 2 Obesity Study with Taldefgrobep Alfa, a Novel Myostatin-Activin Pathway Inhibitor, Completes Enrollment
3/11
10:56 am
bhvn
Biohaven (BHVN) had its price target raised by TD Cowen from $15.00 to $30.00. They now have a "buy" rating on the stock.
Low
Report
Biohaven (BHVN) had its price target raised by TD Cowen from $15.00 to $30.00. They now have a "buy" rating on the stock.
3/9
04:05 pm
bhvn
Biohaven (BHVN) had its "strong-buy" rating reaffirmed by Raymond James Financial, Inc..
Low
Report
Biohaven (BHVN) had its "strong-buy" rating reaffirmed by Raymond James Financial, Inc..
3/4
08:00 am
bhvn
Biohaven (BHVN) had its price target lowered by HC Wainwright from $11.00 to $10.00. They now have a "neutral" rating on the stock.
Low
Report
Biohaven (BHVN) had its price target lowered by HC Wainwright from $11.00 to $10.00. They now have a "neutral" rating on the stock.
3/3
05:03 pm
bhvn
Biohaven (BHVN) had its "outperform" rating reaffirmed by Leerink Partners.
Low
Report
Biohaven (BHVN) had its "outperform" rating reaffirmed by Leerink Partners.
3/3
10:46 am
bhvn
Biohaven (BHVN) had its price target raised by Royal Bank Of Canada from $22.00 to $23.00. They now have an "outperform" rating on the stock.
Low
Report
Biohaven (BHVN) had its price target raised by Royal Bank Of Canada from $22.00 to $23.00. They now have an "outperform" rating on the stock.
3/2
05:07 pm
bhvn
Biohaven Non-GAAP EPS of -$0.90 beats by $0.06 [Seeking Alpha]
Medium
Report
Biohaven Non-GAAP EPS of -$0.90 beats by $0.06 [Seeking Alpha]
3/2
04:22 pm
bhvn
Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Medium
Report
Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/2
04:05 pm
bhvn
Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results
3/2
01:14 pm
bhvn
Pfizer Stock: Buy, Sell or Hold After Its 11% Rally So Far in 2026? [Yahoo! Finance]
Low
Report
Pfizer Stock: Buy, Sell or Hold After Its 11% Rally So Far in 2026? [Yahoo! Finance]
2/28
10:25 am
bhvn
Biohaven Ltd. (BHVN): A Bull Case Theory [Yahoo! Finance]
Low
Report
Biohaven Ltd. (BHVN): A Bull Case Theory [Yahoo! Finance]
2/10
07:01 am
bhvn
Biohaven (NYSE:BHVN) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.
Medium
Report
Biohaven (NYSE:BHVN) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.
2/8
10:25 pm
bhvn
Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity [Seeking Alpha]
Medium
Report
Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity [Seeking Alpha]
2/5
05:11 pm
bhvn
Biohaven (NYSE:BHVN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating on the stock.
Medium
Report
Biohaven (NYSE:BHVN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating on the stock.
1/15
02:00 pm
bhvn
Biohaven CEO Dr. Vlad Coric goes one-on-one with Jim Cramer [CNBC]
Low
Report
Biohaven CEO Dr. Vlad Coric goes one-on-one with Jim Cramer [CNBC]
1/14
07:19 pm
bhvn
Biohaven CEO Dr. Vlad Corcic goes one-on-one with Jim Cramer [CNBC]
Medium
Report
Biohaven CEO Dr. Vlad Corcic goes one-on-one with Jim Cramer [CNBC]
1/12
12:37 pm
bhvn
Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/12
12:07 pm
bhvn
Biohaven Provides Updates on Several Clinical Programs; Shares Rise [Yahoo! Finance]
Medium
Report
Biohaven Provides Updates on Several Clinical Programs; Shares Rise [Yahoo! Finance]
1/12
11:15 am
bhvn
Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference
1/7
07:40 am
bhvn
Biohaven to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 [Yahoo! Finance]
High
Report
Biohaven to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 [Yahoo! Finance]
1/7
07:00 am
bhvn
Biohaven to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026
High
Report
Biohaven to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026
1/6
10:37 am
bhvn
Biohaven (NYSE:BHVN) had its price target lowered by analysts at Morgan Stanley from $26.00 to $21.00. They now have an "overweight" rating on the stock.
Low
Report
Biohaven (NYSE:BHVN) had its price target lowered by analysts at Morgan Stanley from $26.00 to $21.00. They now have an "overweight" rating on the stock.